135 related articles for article (PubMed ID: 12007919)
1. Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord.
Mauborgne A; Poliénor H; Hamon M; Cesselin F; Bourgoin S
Eur J Pharmacol; 2002 Apr; 441(1-2):47-55. PubMed ID: 12007919
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices.
Bourgoin S; Pohl M; Mauborgne A; Benoliel JJ; Collin E; Hamon M; Cesselin F
Neuropharmacology; 1993 Jul; 32(7):633-40. PubMed ID: 7689707
[TBL] [Abstract][Full Text] [Related]
3. gamma-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide- but not that of substance P-like material from rat spinal cord slices.
Bourgoin S; Pohl M; Benoliel JJ; Mauborgne A; Collin E; Hamon M; Cesselin F
Brain Res; 1992 Jun; 583(1-2):344-8. PubMed ID: 1380400
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat.
Nakamura I; Ohta Y; Kemmotsu O
Anesthesiology; 1997 Sep; 87(3):577-84. PubMed ID: 9316963
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats.
Sjölund KF; Sollevi A; Segerdahl M; Lundeberg T
Anesth Analg; 1997 Sep; 85(3):627-32. PubMed ID: 9296420
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat.
Collin E; Frechilla D; Pohl M; Bourgoin S; Mauborgne A; Hamon M; Cesselin F
Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):387-93. PubMed ID: 7520130
[TBL] [Abstract][Full Text] [Related]
7. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.
Vasko MR; Ono H
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):441-6. PubMed ID: 1701522
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.
Nieri P; Martinotti E; Calderone V; Breschi MC
Br J Pharmacol; 2001 Oct; 134(4):745-52. PubMed ID: 11606314
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons.
Carruthers AM; Sellers LA; Jenkins DW; Jarvie EM; Feniuk W; Humphrey PP
Mol Pharmacol; 2001 Jun; 59(6):1533-41. PubMed ID: 11353815
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of strychnine-allodynia is mediated by spinal adenosine A1- but not A2-receptors in the rat.
Khandwala H; Zhang Z; Loomis CW
Brain Res; 1998 Oct; 808(1):106-9. PubMed ID: 9795169
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts.
Monahan TS; Sawmiller DR; Fenton RA; Dobson JG
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1472-81. PubMed ID: 11009431
[TBL] [Abstract][Full Text] [Related]
12. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord.
Santicioli P; Del Bianco E; Tramontana M; Maggi CA
Neurosci Lett; 1992 Sep; 144(1-2):211-4. PubMed ID: 1279486
[TBL] [Abstract][Full Text] [Related]
13. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat.
Ballet S; Mauborgne A; Benoliel JJ; Bourgoin S; Hamon M; Cesselin F; Collin E
Brain Res; 1998 Jun; 796(1-2):198-208. PubMed ID: 9689470
[TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord.
Saria A; Javorsky F; Humpel C; Gamse R
Neuroreport; 1990 Oct; 1(2):104-6. PubMed ID: 1717037
[TBL] [Abstract][Full Text] [Related]
15. The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats.
Ballet S; Aubel B; Mauborgne A; Poliénor H; Farré A; Cesselin F; Hamon M; Bourgoin AS
Neuropharmacology; 2001 Mar; 40(4):578-89. PubMed ID: 11249967
[TBL] [Abstract][Full Text] [Related]
16. Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids.
Bourgoin S; Benoliel JJ; Collin E; Mauborgne A; Pohl M; Hamon M; Cesselin F
Fundam Clin Pharmacol; 1994; 8(4):307-21. PubMed ID: 7851837
[TBL] [Abstract][Full Text] [Related]
17. Increased calcitonin gene-related peptide- and cholecystokinin-like immunoreactivities in spinal motoneurones after dorsal rhizotomy.
Taquet H; Plachot JJ; Pohl M; Collin E; Benoliel JJ; Bourgoin S; Mauborgne A; Meunier JC; Cesselin F; Hamon M
J Neural Transm Gen Sect; 1992; 88(2):127-41. PubMed ID: 1378744
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats.
Oku R; Satoh M; Fujii N; Otaka A; Yajima H; Takagi H
Brain Res; 1987 Feb; 403(2):350-4. PubMed ID: 2435372
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries.
Hedegaard ER; Nielsen BD; Mogensen S; Rembold CM; Frøbert O; Simonsen U
Eur J Pharmacol; 2014 Jan; 723():216-26. PubMed ID: 24309216
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord.
Malcangio M; Garrett NE; Tomlinson DR
Eur J Neurosci; 1997 May; 9(5):1101-4. PubMed ID: 9182964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
